A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

NCT04750577 ·Status: COMPLETED ·Phase: PHASE2

An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

NCT02676401 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

NCT02413398 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

NCT01064414 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

NCT03436693 ·Status: COMPLETED ·Phase: PHASE3

Renal Impairment in Type 2 Diabetic Subjects

NCT00554450 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

NCT05897216 ·Status: COMPLETED ·Phase: PHASE1

OPTIMISE-CKD Drug Utilization

NCT05932901 ·Status: COMPLETED

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

NCT01555008 ·Status: COMPLETED ·Phase: PHASE1

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

NCT01069926 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

NCT04324424 ·Status: COMPLETED ·Phase: PHASE1

Effects of PH3 in Diabetic Nephropathy

NCT01068041 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

NCT02545049 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of AZD5672 in Renally Impaired Subjects

NCT00715702 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

NCT05544214 ·Status: COMPLETED ·Phase: PHASE1

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

NCT00324675 ·Status: COMPLETED ·Phase: NA

A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated

NCT03550378 ·Status: COMPLETED ·Phase: PHASE2

Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes

NCT02317484 ·Status: COMPLETED

Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy

NCT02517320 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease

NCT02512068 ·Status: COMPLETED ·Phase: PHASE3

Real-world Aliskiren Use in Diabetic Patients

NCT01393860 ·Status: COMPLETED

A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

NCT01756716 ·Status: COMPLETED ·Phase: PHASE2

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

NCT03165227 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

NCT00938158 ·Status: COMPLETED ·Phase: PHASE1

This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated

NCT03165240 ·Status: COMPLETED ·Phase: PHASE1